Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Mouse|
|Immunogen||FANCD2 fusion protein|
|Contains||0.1% sodium azide|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|ChIP assay (ChIP)||1:10-1:500|
|Western Blot (WB)||1:1000-1:2000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
By Western blot, this antibody recognizes a band at ~155 and ~162 kDa (post-translationally modified form).
Suggested positive control: Hela whole cell extract.
Fanconi anemia (FANC) is a human autosomal-recessive cancer susceptibility disorder characterized by congenital defects, progressive bone marrow failure, and cellular hypersensitivity to mitomycin C (MMC). The FANC subunit D2 protein is vital for cellular resistance to DNA cross-linking and the arrest of DNA synthesis after ionizing radiation. DNA damage activates the monoubiquitination of FANCD2, targeting nuclear foci containing the BRCA1 protein.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
FA4; FACD; FAD; FAD2; FANCD; FANCONI ANEMIA COMPLEMENTATION GROUP D; Fanconi anemia, complementation group D2; FANCONI PANCYTOPENIA TYPE 4
FA-D2; FA4; FACD; FAD; FAD2; FANCD; FANCD2